Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
Recruiting now
Conditions studied: Lung Cancer, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Non Small Cell Lung Cancer, Small-cell Lung Cancer
In brief
This study is a multi-center, observational, real-world study for patients with resected lung cancers in China. With the help of a properly designed data processing algorithm and extensively performed data quality assurance, this study aims to harness the potential of real-world big data to (1) describe characteristics and treatment patterns and their evolving trends; (2) discover features associated with overall survival; and (3) address recently-emerging clinical questions.
Key facts
- Study ID
- NCT06255197
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- People needed
- 60000
- Starts
- 2019-11-04
- Expected to finish
- 2031-12-31
- Last updated by the study team
- 2024-02-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age above 18.
- Have received surgical resection for lung malignancies.
You may not qualify if…
- Participants whose data are of low quality, poor completeness or poor internal linkage.
Where it is running
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College — Beijing, Beijing Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.